Tech Company Financing Transactions

Raven Biotechnologies Funding Round

Bear Stearns Health Innoventures, FirstMark Capital and Integral Capital Partners joined a $40 million Series C capital raise for Raven Biotechnologies. The funding round was announced on 1/2/2003.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

One Corporate Drive
South San Francisco, CA 94080
USA

Phone

650.624.2600

Website

www.ravenbio.com

Email Address

[email protected]

Overview

Raven's approach creates the optimal starting point for developing a new drug with an increased probability of success in the clinic, within a substantially compressed time frame for drug lead development.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

George Schreiner

        

Chief Operating Officer

John Whelan

        

Chief Scientific Officer

Jennie Mather

        

Vice President

Carolyn Adler

        

Vice President

Stanford Stewart

        

VP - Manufacturing

Lucille Chang

        

Browse more venture capital transactions:

Prev: 12/31/2002: RAD Electronics venture capital transaction
Next: 1/3/2003: TolerRx venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary